4basebio agrees to extend 2Invest loan maturity to October 2030

4basebio agreed on October 15, 2026, to extend its fully drawn €25 million shareholder loan from 2Invest by two years to October 31, 2030. 2Invest will exchange approximately £4 million of principal and accrued interest for 776,699 Subscription Shares, reducing outstanding principal to €21.08 million. A separate cash subscription by 2Invest will raise approximately £1 million through 194,174 Subscription Shares. The loan amendment and subscriptions depend on completion of the placing and remaining subscriptions; the capital raise requires shareholder approval. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4BASEBIO plc published the original content used to generate this news brief via (Ref. ID: 202610151015PR_NEWS_PRUKDSCX_0092) on October 15, 2026, and is solely responsible for the information contained therein. (C)